These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 2085427)

  • 41. Ultrafiltration of dialysis fluid to obtain a sterile solution during hemodialysis.
    Bambauer R; Walther J; Jung WK
    Blood Purif; 1990; 8(6):309-17. PubMed ID: 2093329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro assessment of dialysis membrane as an endotoxin transfer barrier: geometry, morphology, and permeability.
    Henrie M; Ford C; Andersen M; Stroup E; Diaz-Buxo J; Madsen B; Britt D; Ho CH
    Artif Organs; 2008 Sep; 32(9):701-10. PubMed ID: 18684209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers.
    Sundaram S; Barrett TW; Meyer KB; Perrella C; Neto MC; King AJ; Pereira BJ
    J Am Soc Nephrol; 1996 Oct; 7(10):2183-91. PubMed ID: 8915979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Backdiffusion rather than backfiltration enhances endotoxin transport through highly permeable dialysis membranes.
    Hosoya N; Sakai K
    ASAIO Trans; 1990; 36(3):M311-3. PubMed ID: 2252686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Easy production of sterile, pyrogen-free dialysate.
    Erley CM; von Herrath D; Hartenstein-Koch K; Kutschera D; Amir-Moazami B; Schaefer K
    ASAIO Trans; 1988; 34(3):205-7. PubMed ID: 3196509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phagocytic activity of leukocytes induced by different dialyzer membranes.
    Vanholder R; Dhondt A; Van Landschoot N; Waterloos MA; Ringoir S
    Contrib Nephrol; 1989; 74():86-90. PubMed ID: 2518453
    [No Abstract]   [Full Text] [Related]  

  • 47. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
    Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
    Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction of mononuclear cytokine production in hemodialysis patients treated with steam-sterilized low-flux polysulphone membranes.
    Aucella F; Vigilante M; Grandone E; Colaizzo D; Margaglione M; Modoni S; Orlandini G; Stallone C
    Int J Artif Organs; 1998 Apr; 21(4):210-5. PubMed ID: 9649062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dialyzer reuse--part II: advantages and disadvantages.
    Twardowski ZJ
    Semin Dial; 2006; 19(3):217-26. PubMed ID: 16689973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contamination of dialysis water and dialysate. A survey of 30 centers.
    Bambauer R; Schauer M; Jung WK; Daum V; Vienken J
    ASAIO J; 1994; 40(4):1012-6. PubMed ID: 7858320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Production of cytokines in hemodialysis.
    Tetta C; Camussi G; Turello E; Salomone M; Aimo G; Priolo G; Segoloni G; Vercellone A
    Blood Purif; 1990; 8(6):337-46. PubMed ID: 2093331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pyrogen transfer across high- and low-flux hemodialysis membranes.
    Weber V; Linsberger I; Rossmanith E; Weber C; Falkenhagen D
    Artif Organs; 2004 Feb; 28(2):210-7. PubMed ID: 14961961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypersensitivity reactions to synthetic haemodialysis membranes — an emerging issue?
    Alvarez-de Lara MA; Martín-Malo A
    Nefrologia; 2014 Nov; 34(6):698-702. PubMed ID: 25415569
    [No Abstract]   [Full Text] [Related]  

  • 54. Sterile versus non-sterile dialysis fluid in chronic hemodialysis treatment.
    Bambauer R; Meyer S; Jung H; Goehl H; Nystrand R
    ASAIO Trans; 1990; 36(3):M317-20. PubMed ID: 2252688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microbial and endotoxin contamination in water and dialysate in the central United States.
    Klein E; Pass T; Harding GB; Wright R; Million C
    Artif Organs; 1990 Apr; 14(2):85-94. PubMed ID: 2350260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endotoxins modulate chronically tumour necrosis factor alpha and interleukin 6 release by uraemic monocytes.
    Pertosa G; Gesualdo L; Bottalico D; Schena FP
    Nephrol Dial Transplant; 1995; 10(3):328-33. PubMed ID: 7792027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of different dialyzer membranes on serum angiotensin-converting enzyme during hemodialysis.
    Docci D; Delvecchio C; Turci F; Baldrati L; Gollini C
    Int J Artif Organs; 1988 Jan; 11(1):28-32. PubMed ID: 2834297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes.
    Pereira BJ; Snodgrass BR; Hogan PJ; King AJ
    Kidney Int; 1995 Feb; 47(2):603-10. PubMed ID: 7723247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacteria- and endotoxin-free dialysis fluid for use in chronic hemodialysis.
    Bambauer R; Walther J; Meyer S; Ost S; Schauer M; Jung WK; Göhl H; Vienken J
    Artif Organs; 1994 Mar; 18(3):188-92. PubMed ID: 8185483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers.
    Teehan GS; Guo D; Perianayagam MC; Balakrishnan VS; Pereira BJ; Jaber BL
    Blood Purif; 2004; 22(4):329-37. PubMed ID: 15240988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.